Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective Disorder

Clinical trial NCT00395031 · COMPLETED

Trial details

NCT number: NCT00395031
Sponsor: Manhattan Psychiatric Center
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder

Start date: 2003-09-01
Primary completion: 2010-01-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.